MedPath

The effect of chia seeds on non-alcoholic fatty liver disease

Phase 3
Recruiting
Conditions
on-alcoholic fatty liver disease.
Fatty (change of) liver, not elsewhere classified
K76.0
Registration Number
IRCT20100209003320N23
Lead Sponsor
Tabriz University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
38
Inclusion Criteria

Both genders
Age range of 18 to 60 years
body mass index= 30- 39.9 Kg/m2
Hepatic steatosis based on ultrasound findings (grade 1 and 2)
willingness to participate in the study

Exclusion Criteria

Athletes
pregnancy
breastfeeding
menopause
Under infertility treatment
taking birth control pills
estrogen therapy
Smoking
history of alcohol consumption
Taking medications including chemical or herbal medications for weight loss
anti-hypertensive
Fat-lowering drugs
Sugar-lowering drugs
any nutritional supplements from 3 months before the study
Having cardiovascular diseases
Liver dysfunction
Kidney dysfunction
Intestinal dysfunction
Thyroid dysfunction
Parathyroid dysfunction
known autoimmune diseases
polycystic ovary syndrome
cancers
Following a special diet in the last three months
performing weight loss surgery in the last one year
Taking Phenytoin medicine
Taking amoxifene medicine
Taking lithium medicine
Performing or being a candidate for liver transplantation

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath